Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Zenapax data

PDLI and partner Hoffmann-La Roche Inc. (Nutley, N.J.) presented results of a Phase I/II double-blind placebo-controlled trial at the meeting

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE